載入...

Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.

The new selective 5-HT2 receptor blocking agent ketanserin was given in a dose of 10 mg intravenously to 12 patients with essential hypertension. It caused a distinct fall in supine systemic arterial, right atrial, pulmonary artery, and pulmonary capillary "wedge" pressures. Cardiac output...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Wenting, G J, Man in 't Veld, A J, Woittiez, A J, Boomsma, F, Schalekamp, M A
格式: Artigo
語言:Inglês
出版: 1982
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC1496107/
https://ncbi.nlm.nih.gov/pubmed/6800533
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!